Nomogram for predicting PCa recurrence is validated

New York-A computer model nomogram that uses three preoperative prostate cancer variables to predict probabilities for cancer recurrence within 5 years has been successfully validated. The nomogram will not only aid physicians in making treatment decisions, but it could also help improve patients' ability to make decisions about their treatment, according to researchers from Memorial Sloan-Kettering Cancer Center in New York.

Related Videos

Related Content

Advertisement

December 26th 2024

Top 10 BPH articles and videos of 2024

Benjamin P. Saylor

As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

December 24th 2024

Quiz: CUA guidelines on specimen and timing considerations with genetic testing

Patrick Campbell

Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

December 23rd 2024

FDA approves vibegron for OAB symptoms in pharmacologically treated BPH

Hannah Clarke

The approval of vibegron is supported by data from the phase 3 COURAGE trial.

December 23rd 2024

Navigating work-life balance: VUMC’s Family Planning for Surgeons Series

Lauren E. Corona, MD

"I hope that [attendees] will be exposed to a community where they feel that they're able to freely ask questions, gain accurate information, and feel heard, validated, and connected," says Lauren E. Corona, MD.

Related Content

Advertisement

December 26th 2024

Top 10 BPH articles and videos of 2024

Benjamin P. Saylor

As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

December 24th 2024

Quiz: CUA guidelines on specimen and timing considerations with genetic testing

Patrick Campbell

Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

December 23rd 2024

FDA approves vibegron for OAB symptoms in pharmacologically treated BPH

Hannah Clarke

The approval of vibegron is supported by data from the phase 3 COURAGE trial.

December 23rd 2024

Navigating work-life balance: VUMC’s Family Planning for Surgeons Series

Lauren E. Corona, MD

"I hope that [attendees] will be exposed to a community where they feel that they're able to freely ask questions, gain accurate information, and feel heard, validated, and connected," says Lauren E. Corona, MD.